Murata Y - Search Results

1

Meningioma in a woman receiving hormone therapy.

Murata Y, Takeuchi S, Yoshida S, Miyoshi I. Murata Y, et al. Intern Med. 2003 Dec;42(12):1267. doi: 10.2169/internalmedicine.42.1267. Intern Med. 2003. PMID: 14714974 Free article. No abstract available.

2

Microbleeding in the head of caudate nuclei of a patient with hypertension.

Murata Y, Takeuchi S, Ue H, Mizobuchi H, Shimizu K, Yoshida S. Murata Y, et al. Intern Med. 2004 Nov;43(11):1089-90. doi: 10.2169/internalmedicine.43.1089. Intern Med. 2004. PMID: 15609711 Free article. No abstract available.

3

Hemorrhagic cerebral metastases from thyroid cancer on T2*-weighted gradient echo MRI.

Murata Y, Itoh S, Morio K, Sasaki T, Mizobuchi H, Shimizu K, Yoshida S. Murata Y, et al. Magn Reson Imaging. 2004 Apr;22(3):435-9. doi: 10.1016/j.mri.2004.01.017. Magn Reson Imaging. 2004. PMID: 15062942

4

Scintigraphic prediction of response to chemotherapy in patients with breast cancer: Technetium 99m-tetrofosmin and thallium-201 dual single photon emission computed tomography.

Takeuchi N, Fukumoto M, Nishioka A, Akagi N, Murata Y, Takeuchi S, Ogawa Y, Yoshida S. Takeuchi N, et al. Among authors: murata y. Int J Oncol. 2002 Jan;20(1):53-8. Int J Oncol. 2002. PMID: 11743642

5

Tamoxifen-induced non-alcoholic steatohepatitis in patients with breast cancer: determination of a suitable biopsy site for diagnosis.

Murata Y, Ogawa Y, Saibara T, Nishioka A, Takeuchi N, Kariya S, Onishi S, Yoshida S. Murata Y, et al. Oncol Rep. 2003 Jan-Feb;10(1):97-100. Oncol Rep. 2003. PMID: 12469151

6

Pituitary stalk metastasis from breast cancer treated with systemic chemotherapy.

Murata Y, Ogawa Y, Yokoe I, Kariya S, Morio K, Sasaki T, Nishioka A, Yoshida S. Murata Y, et al. Oncol Rep. 2003 Nov-Dec;10(6):1973-5. Oncol Rep. 2003. PMID: 14534728

7

CT profile curves of peripheral pulmonary adenocarcinoma of the lung: correlations with Noguchi type.

Murata Y, Kubota K, Itoh S, Fukumoto M, Ohara S, Yoshida S. Murata Y, et al. Radiat Med. 2004 Jan-Feb;22(1):20-4. Radiat Med. 2004. PMID: 15053171

8

Utility of initial MRI for predicting extent of residual disease after neoadjuvant chemotherapy: analysis of 70 breast cancer patients.

Murata Y, Ogawa Y, Yoshida S, Kubota K, Itoh S, Fukumoto M, Nishioka A, Moriki T, Maeda H, Tanaka Y. Murata Y, et al. Oncol Rep. 2004 Dec;12(6):1257-62. Oncol Rep. 2004. PMID: 15547747

9

Relationship between hormonal receptors, HER-2, p53 protein, Bcl-2, and MIB-1 status and the antitumor effects of neoadjuvant anthracycline-based chemotherapy in invasive breast cancer patients.

Kariya S, Ogawa Y, Nishioka A, Moriki T, Ohnishi T, Ito S, Murata Y, Yoshida S. Kariya S, et al. Among authors: murata y. Radiat Med. 2005 May;23(3):189-94. Radiat Med. 2005. PMID: 15940066

10

Follow-up CT findings of tamoxifen-induced non-alcoholic steatohepatitis (NASH) of breast cancer patients treated with bezafibrate.

Ogawa Y, Murata Y, Saibara T, Nishioka A, Kariya S, Yoshida S. Ogawa Y, et al. Among authors: murata y. Oncol Rep. 2003 Sep-Oct;10(5):1473-8. Oncol Rep. 2003. PMID: 12883726

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,749 results

Search Page

Filters